Refresher Course: Emergency Imaging

Emergencies in oncologic patients: imaging approach and impact of complication findings

Lectures

1
RC 517-1 - Chairperson's introduction

RC 517-1 - Chairperson's introduction

05:18Raffaella Basilico

2
RC 517-2 - Oncology patients in ED with neurological symptoms: the role of imaging

RC 517-2 - Oncology patients in ED with neurological symptoms: the role of imaging

15:51Maureen Dumba

1.To be able to compare and contrast appropriate imaging techniques available in oncologic emergencies of the CNS.
2. To distinguish the imaging features of common primary and secondary CNS oncological pathologies to formulate a differential diagnosis.
3. To recognise the imaging features of life-threatening conditions in the CNS resulting from neoplastic causes or treatment-related complications."

3
RC 517-3 - Mass, emboli, toxication, and immune mediated disease: malignancy-related emergencies in the chest

RC 517-3 - Mass, emboli, toxication, and immune mediated disease: malignancy-related emergencies in the chest

15:24Frank Berger

1. To learn about imaging features of oncology patients presenting to the emergency department with respiratory symptoms.
2. To differentiate between oncologic and non-oncologic causes of lung emergencies.
3. To become familiar with imaging features of cancer treatment-related changes in the lungs, including effects of cytotoxic and molecular targeted therapies.

4
RC 517-4 - Abdominal emergencies in oncologic patients: obstruction, perforation, and vascular impairment

RC 517-4 - Abdominal emergencies in oncologic patients: obstruction, perforation, and vascular impairment

15:42Alexandra Platon

1. To become familiar with the most frequent causes of acute abdomen emergencies in oncologic patients.
2. To learn about the imaging algorithm in oncology patients presenting to the emergency department with acute abdominal pain.
3. To become familiar with vascular impairment findings in abdominal viscera of oncologic patients.

5
RC 517-5 - Panel discussion

RC 517-5 - Panel discussion

06:01